Jefferies Financial Group’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Jefferies Financial Group's GPCR Position: Q3 2026 in Review
Jefferies Financial Group increased its Structure Therapeutics (GPCR) stake by 201% in Q3 2026, buying an estimated $3.83M and bringing the position to 122,322 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #701.
Jefferies Financial Group first reported a position in GPCR in Q1 2024 and has held it in 8 quarters since. The position peaked at $7.16M in Q4 2025. 170 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Jefferies Financial Group held 122,322 shares of Structure Therapeutics worth $1.28M as of Q3 2026.
- Jefferies Financial Group bought 81,697 Structure Therapeutics shares in Q3 2026, an estimated $3.83M.
- Structure Therapeutics made up 0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #701 holding.
- Jefferies Financial Group first reported a position in Structure Therapeutics in Q1 2024 and has held it in 8 quarters since.
- Jefferies Financial Group's Structure Therapeutics position peaked at $7.16M in Q4 2025.
- 170 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.